title: Protocol biopsy-driven interventions after pediatric renal transplantation.
abstract: The therapeutic value of protocol biopsies (PBs) in renal transplant recipients remains unclear. We performed protocol biopsies in 57 children six months after transplantation. We increased the CNI dose in patients with borderline findings. In cases of Banff grade Ia, six prednisolone IV-pulses were given and the CNI dose was increased. CNI toxicity and polyomavirus nephropathy led to a reduction in the CNI dose. GFR was compared with a control group of 51 children with no PBs transplanted in the same period. Forty-two percent of PBs had no pathological changes, 24% IF/TA. Borderline findings were detected in 11%, Banff grade Ia in 15% (CNI), toxicity in 8%, and one case showed polyomavirus nephropathy. GFR after 1.5 and 2.5 yr was similar in both groups. GFR 3.5 yr after transplantation was significantly higher in the intervention group (57 ± 17 vs. 46 ± 20). Patients treated with low-dose CNI and everolimus had a significantly lower number of pathological findings in PBs. The performance of protocol biopsies followed by a standardized treatment algorithm led to better graft function 3.5 yr after transplantation. Prospective randomized studies to confirm our findings are needed.
authors.affiliation: Department of Pediatrics, Hannover Medical School, Hannover, Germany. Kanzelmeyer.Nele@mh-hannover.de
authors.forename: N K
authors.initials: NK
authors.lastname: Kanzelmeyer
authors.forename: T
authors.initials: T
authors.lastname: Ahlenstiel
authors.forename: J
authors.initials: J
authors.lastname: Drube
authors.forename: K
authors.initials: K
authors.lastname: Froede
authors.forename: M
authors.initials: M
authors.lastname: Kreuzer
authors.forename: V
authors.initials: V
authors.lastname: Broecker
authors.forename: J H H
authors.initials: JH
authors.lastname: Ehrich
authors.forename: A
authors.initials: A
authors.lastname: Melk
authors.forename: L
authors.initials: L
authors.lastname: Pape
mesh_terms: D000367:Age Factors; D000465:Algorithms; D000704:Analysis of Variance; D001706:Biopsy / Q000379:methods*; D065095:Calcineurin Inhibitors; D002648:Child; D002985:Clinical Protocols; D005260:Female; D006084:Graft Rejection / Q000175:diagnosis; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000473:pathology*; D008297:Male; D011183:Postoperative Complications / Q000175:diagnosis*
chemical_list: D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents